Overview

Metformin for Weight Loss in Schizophrenia

Status:
Terminated

Trial end date:
2011-04-01

Target enrollment:

Participant gender:

Summary

Study hypothesis is that patients on antipsychotics medication treated with metformin will show loss in weight and improved measures of glucose metabolism.

Phase:

N/A

Details

Lead Sponsor:

Nathan Kline Institute for Psychiatric Research

Treatments:

Antipsychotic Agents
Metformin